Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 1041 entries
Sorted by: Best Match Show Resources per page
[No title available]

mSphere

Meyerett-Reid C, Wyckoff AC, Spraker T, Pulford B, Bender H, Zabel MD.
PMID: 28144628
mSphere. 2017 Jan 25;2(1). doi: 10.1128/mSphere.00372-16. eCollection 2017.

Substantial evidence supports the hypothesis that prions are misfolded, infectious, insoluble, and protease-resistant proteins (PrP

Cite
Meyerett-Reid C, Wyckoff AC, Spraker T, et al. . mSphere. 2017;2(1)doi: 10.1128/mSphere.00372-16.
Meyerett-Reid, C., Wyckoff, A. C., Spraker, T., Pulford, B., Bender, H., & Zabel, M. D. (2017). . mSphere, 2(1), . https://doi.org/10.1128/mSphere.00372-16
Meyerett-Reid, Crystal, et al. "." mSphere vol. 2,1 (2017). doi: https://doi.org/10.1128/mSphere.00372-16
Meyerett-Reid C, Wyckoff AC, Spraker T, Pulford B, Bender H, Zabel MD. . mSphere. 2017 Jan 25;2(1). doi: 10.1128/mSphere.00372-16. eCollection 2017. PMID: 28144628; PMCID: PMC5266495.
Copy Download .nbib Format: NLM
Determination of the partition coefficients of the nonionic detergent C12E 7 between lipid-detergent mixed membranes and water by means of Laurdan fluorescence spectroscopy.

Journal of fluorescence

Heerklotz H, Binder H, Lantzsch G.
PMID: 24233613
J Fluoresc. 1994 Dec;4(4):349-52. doi: 10.1007/BF01881454.

The membrane-water partition coefficient of the detergent C12E7 between water and C12E7/POPC mixed membranes has been determined by means of steady-state fluorescence spectroscopy. The emission spectra of the fluorescent probe Laurdan were used as an indicator of membrane composition...

Cite
Heerklotz H, Binder H, Lantzsch G. Determination of the partition coefficients of the nonionic detergent C12E 7 between lipid-detergent mixed membranes and water by means of Laurdan fluorescence spectroscopy. J Fluoresc. 1994;4(4):349-52doi: 10.1007/BF01881454.
Heerklotz, H., Binder, H., & Lantzsch, G. (1994). Determination of the partition coefficients of the nonionic detergent C12E 7 between lipid-detergent mixed membranes and water by means of Laurdan fluorescence spectroscopy. Journal of fluorescence, 4(4), 349-52. https://doi.org/10.1007/BF01881454
Heerklotz, H, et al. "Determination of the partition coefficients of the nonionic detergent C12E 7 between lipid-detergent mixed membranes and water by means of Laurdan fluorescence spectroscopy." Journal of fluorescence vol. 4,4 (1994): 349-52. doi: https://doi.org/10.1007/BF01881454
Heerklotz H, Binder H, Lantzsch G. Determination of the partition coefficients of the nonionic detergent C12E 7 between lipid-detergent mixed membranes and water by means of Laurdan fluorescence spectroscopy. J Fluoresc. 1994 Dec;4(4):349-52. doi: 10.1007/BF01881454. PMID: 24233613.
Copy Download .nbib Format: NLM
Health Economic Evaluation of Canagliflozin In The Treatment of Type 2 Diabetes Mellitus In Slovakia.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Troelsgaard A, Pitcher A, Binder R, Stetka R, Ondrusova M, Lovato E, Hemels M.
PMID: 27200647
Value Health. 2014 Nov;17(7):A345. doi: 10.1016/j.jval.2014.08.698. Epub 2014 Oct 26.

No abstract available.

Cite
Troelsgaard A, Pitcher A, Binder R, et al. Health Economic Evaluation of Canagliflozin In The Treatment of Type 2 Diabetes Mellitus In Slovakia. Value Health. 2014;17(7):A345doi: 10.1016/j.jval.2014.08.698.
Troelsgaard, A., Pitcher, A., Binder, R., Stetka, R., Ondrusova, M., Lovato, E., & Hemels, M. (2014). Health Economic Evaluation of Canagliflozin In The Treatment of Type 2 Diabetes Mellitus In Slovakia. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A345. https://doi.org/10.1016/j.jval.2014.08.698
Troelsgaard, A, et al. "Health Economic Evaluation of Canagliflozin In The Treatment of Type 2 Diabetes Mellitus In Slovakia." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A345. doi: https://doi.org/10.1016/j.jval.2014.08.698
Troelsgaard A, Pitcher A, Binder R, Stetka R, Ondrusova M, Lovato E, Hemels M. Health Economic Evaluation of Canagliflozin In The Treatment of Type 2 Diabetes Mellitus In Slovakia. Value Health. 2014 Nov;17(7):A345. doi: 10.1016/j.jval.2014.08.698. Epub 2014 Oct 26. PMID: 27200647.
Copy Download .nbib Format: NLM
Whole Genome Expression Analysis in a Mouse Model of Tauopathy Identifies MECP2 as a Possible Regulator of Tau Pathology.

Frontiers in molecular neuroscience

Maphis NM, Jiang S, Binder J, Wright C, Gopalan B, Lamb BT, Bhaskar K.
PMID: 28367114
Front Mol Neurosci. 2017 Mar 17;10:69. doi: 10.3389/fnmol.2017.00069. eCollection 2017.

Increasing evidence suggests that hyperphosphorylation and aggregation of microtubule-associated protein tau (MAPT or tau) correlates with the development of cognitive impairment in Alzheimer's disease (AD) and related tauopathies. While numerous attempts have been made to model AD-relevant tau pathology...

Cite
Maphis NM, Jiang S, Binder J, et al. Whole Genome Expression Analysis in a Mouse Model of Tauopathy Identifies MECP2 as a Possible Regulator of Tau Pathology. Front Mol Neurosci. 2017;10:69doi: 10.3389/fnmol.2017.00069.
Maphis, N. M., Jiang, S., Binder, J., Wright, C., Gopalan, B., Lamb, B. T., & Bhaskar, K. (2017). Whole Genome Expression Analysis in a Mouse Model of Tauopathy Identifies MECP2 as a Possible Regulator of Tau Pathology. Frontiers in molecular neuroscience, 1069. https://doi.org/10.3389/fnmol.2017.00069
Maphis, Nicole M, et al. "Whole Genome Expression Analysis in a Mouse Model of Tauopathy Identifies MECP2 as a Possible Regulator of Tau Pathology." Frontiers in molecular neuroscience vol. 10 (2017): 69. doi: https://doi.org/10.3389/fnmol.2017.00069
Maphis NM, Jiang S, Binder J, Wright C, Gopalan B, Lamb BT, Bhaskar K. Whole Genome Expression Analysis in a Mouse Model of Tauopathy Identifies MECP2 as a Possible Regulator of Tau Pathology. Front Mol Neurosci. 2017 Mar 17;10:69. doi: 10.3389/fnmol.2017.00069. eCollection 2017. PMID: 28367114; PMCID: PMC5355442.
Copy Download .nbib Format: NLM
[Not Available].

Ceska gynekologie

Procházka M, Velebil P, Binder T.
PMID: 27457390
Ceska Gynekol. 2016 Apr;81(2):92.

No abstract available.

Cite
Procházka M, Velebil P, Binder T. POROD VELKÉHO PLODU. [Not Available]. Ceska Gynekol. 2016;81(2):92
Procházka, M., Velebil, P., & Binder, T. (2016). POROD VELKÉHO PLODU. [Not Available]. Ceska gynekologie, 81(2), 92.
Procházka, M, et al. "POROD VELKÉHO PLODU." [Not Available]. Ceska gynekologie vol. 81,2 (2016): 92.
Procházka M, Velebil P, Binder T. POROD VELKÉHO PLODU. [Not Available]. Ceska Gynekol. 2016 Apr;81(2):92. Czech. PMID: 27457390.
Copy Download .nbib Format: NLM
Natriuretic peptides for the detection of paroxysmal atrial fibrillation.

Open heart

Seegers J, Zabel M, Grüter T, Ammermann A, Weber-Krüger M, Edelmann F, Gelbrich G, Binder L, Herrmann-Lingen C, Gröschel K, Hasenfuß G, Feltgen N, Pieske B, Wachter R.
PMID: 26288739
Open Heart. 2015 Aug 03;2(1):e000182. doi: 10.1136/openhrt-2014-000182. eCollection 2015.

BACKGROUND AND PURPOSE: Silent atrial fibrillation (AF) and tachycardia (AT) are considered precursors of ischaemic stroke. Therefore, detection of paroxysmal atrial rhythm disorders is highly relevant, but is clinically challenging. We aimed to evaluate the diagnostic value of natriuretic...

Cite
Seegers J, Zabel M, Grüter T, et al. Natriuretic peptides for the detection of paroxysmal atrial fibrillation. Open Heart. 2015;2(1):e000182doi: 10.1136/openhrt-2014-000182.
Seegers, J., Zabel, M., Grüter, T., Ammermann, A., Weber-Krüger, M., Edelmann, F., Gelbrich, G., Binder, L., Herrmann-Lingen, C., Gröschel, K., Hasenfuß, G., Feltgen, N., Pieske, B., & Wachter, R. (2015). Natriuretic peptides for the detection of paroxysmal atrial fibrillation. Open heart, 2(1), e000182. https://doi.org/10.1136/openhrt-2014-000182
Seegers, Joachim, et al. "Natriuretic peptides for the detection of paroxysmal atrial fibrillation." Open heart vol. 2,1 (2015): e000182. doi: https://doi.org/10.1136/openhrt-2014-000182
Seegers J, Zabel M, Grüter T, Ammermann A, Weber-Krüger M, Edelmann F, Gelbrich G, Binder L, Herrmann-Lingen C, Gröschel K, Hasenfuß G, Feltgen N, Pieske B, Wachter R. Natriuretic peptides for the detection of paroxysmal atrial fibrillation. Open Heart. 2015 Aug 03;2(1):e000182. doi: 10.1136/openhrt-2014-000182. eCollection 2015. PMID: 26288739; PMCID: PMC4533200.
Copy Download .nbib Format: NLM
Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours.

Oncogene

Yurugi H, Marini F, Weber C, David K, Zhao Q, Binder H, Désaubry L, Rajalingam K.
PMID: 28846116
Oncogene. 2017 Oct 19;36(42):5914. doi: 10.1038/onc.2017.307. Epub 2017 Aug 28.

This corrects the article DOI: 10.1038/onc.2017.93.

Cite
Yurugi H, Marini F, Weber C, et al. Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours. Oncogene. 2017;36(42):5914doi: 10.1038/onc.2017.307.
Yurugi, H., Marini, F., Weber, C., David, K., Zhao, Q., Binder, H., Désaubry, L., & Rajalingam, K. (2017). Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours. Oncogene, 36(42), 5914. https://doi.org/10.1038/onc.2017.307
Yurugi, H, et al. "Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours." Oncogene vol. 36,42 (2017): 5914. doi: https://doi.org/10.1038/onc.2017.307
Yurugi H, Marini F, Weber C, David K, Zhao Q, Binder H, Désaubry L, Rajalingam K. Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours. Oncogene. 2017 Oct 19;36(42):5914. doi: 10.1038/onc.2017.307. Epub 2017 Aug 28. PMID: 28846116.
Copy Download .nbib Format: NLM
Preparation of a Binder-Free Three-Dimensional Carbon Foam/Silicon Composite as Potential Material for Lithium Ion Battery Anodes.

ACS applied materials & interfaces

Roy AK, Zhong M, Schwab MG, Binder A, Venkataraman SS, Tomović Ž.
PMID: 26909748
ACS Appl Mater Interfaces. 2016 Mar 23;8(11):7343-8. doi: 10.1021/acsami.5b12026. Epub 2016 Mar 09.

We report a novel three-dimensional nitrogen containing carbon foam/silicon (CFS) composite as potential material for lithium ion battery anodes. Carbon foams were prepared by direct carbonization of low cost, commercially available melamine formaldehyde (MF, Basotect) foam precursors. The carbon...

Cite
Roy AK, Zhong M, Schwab MG, et al. Preparation of a Binder-Free Three-Dimensional Carbon Foam/Silicon Composite as Potential Material for Lithium Ion Battery Anodes. ACS Appl Mater Interfaces. 2016;8(11):7343-8doi: 10.1021/acsami.5b12026.
Roy, A. K., Zhong, M., Schwab, M. G., Binder, A., Venkataraman, S. S., & Tomović, �. �. (2016). Preparation of a Binder-Free Three-Dimensional Carbon Foam/Silicon Composite as Potential Material for Lithium Ion Battery Anodes. ACS applied materials & interfaces, 8(11), 7343-8. https://doi.org/10.1021/acsami.5b12026
Roy, Amit K, et al. "Preparation of a Binder-Free Three-Dimensional Carbon Foam/Silicon Composite as Potential Material for Lithium Ion Battery Anodes." ACS applied materials & interfaces vol. 8,11 (2016): 7343-8. doi: https://doi.org/10.1021/acsami.5b12026
Roy AK, Zhong M, Schwab MG, Binder A, Venkataraman SS, Tomović Ž. Preparation of a Binder-Free Three-Dimensional Carbon Foam/Silicon Composite as Potential Material for Lithium Ion Battery Anodes. ACS Appl Mater Interfaces. 2016 Mar 23;8(11):7343-8. doi: 10.1021/acsami.5b12026. Epub 2016 Mar 09. PMID: 26909748.
Copy Download .nbib Format: NLM
Immunosuppressant MPA Modulates Tight Junction through Epigenetic Activation of MLCK/MLC-2 Pathway via p38MAPK.

Frontiers in physiology

Khan N, Pantakani DV, Binder L, Qasim M, Asif AR.
PMID: 26733876
Front Physiol. 2015 Dec 22;6:381. doi: 10.3389/fphys.2015.00381. eCollection 2015.

BACKGROUND: Mycophenolic acid (MPA) is an important immunosuppressive drug (ISD) prescribed to prevent graft rejection in the organ transplanted patients, however, its use is also associated with adverse side effects like sporadic gastrointestinal (GI) disturbances. Recently, we reported the...

Cite
Khan N, Pantakani DV, Binder L, et al. Immunosuppressant MPA Modulates Tight Junction through Epigenetic Activation of MLCK/MLC-2 Pathway via p38MAPK. Front Physiol. 2015;6:381doi: 10.3389/fphys.2015.00381.
Khan, N., Pantakani, D. V., Binder, L., Qasim, M., & Asif, A. R. (2015). Immunosuppressant MPA Modulates Tight Junction through Epigenetic Activation of MLCK/MLC-2 Pathway via p38MAPK. Frontiers in physiology, 6381. https://doi.org/10.3389/fphys.2015.00381
Khan, Niamat, et al. "Immunosuppressant MPA Modulates Tight Junction through Epigenetic Activation of MLCK/MLC-2 Pathway via p38MAPK." Frontiers in physiology vol. 6 (2015): 381. doi: https://doi.org/10.3389/fphys.2015.00381
Khan N, Pantakani DV, Binder L, Qasim M, Asif AR. Immunosuppressant MPA Modulates Tight Junction through Epigenetic Activation of MLCK/MLC-2 Pathway via p38MAPK. Front Physiol. 2015 Dec 22;6:381. doi: 10.3389/fphys.2015.00381. eCollection 2015. PMID: 26733876; PMCID: PMC4687409.
Copy Download .nbib Format: NLM
Incidence of Dementia over Three Decades in the Framingham Heart Study.

The New England journal of medicine

Binder N, Schumacher M.
PMID: 27406363
N Engl J Med. 2016 Jul 07;375(1):92-3. doi: 10.1056/NEJMc1604823.

No abstract available.

Cite
Binder N, Schumacher M. Incidence of Dementia over Three Decades in the Framingham Heart Study. N Engl J Med. 2016;375(1):92-3doi: 10.1056/NEJMc1604823.
Binder, N., & Schumacher, M. (2016). Incidence of Dementia over Three Decades in the Framingham Heart Study. The New England journal of medicine, 375(1), 92-3. https://doi.org/10.1056/NEJMc1604823
Binder, Nadine, and Schumacher, Martin. "Incidence of Dementia over Three Decades in the Framingham Heart Study." The New England journal of medicine vol. 375,1 (2016): 92-3. doi: https://doi.org/10.1056/NEJMc1604823
Binder N, Schumacher M. Incidence of Dementia over Three Decades in the Framingham Heart Study. N Engl J Med. 2016 Jul 07;375(1):92-3. doi: 10.1056/NEJMc1604823. PMID: 27406363.
Copy Download .nbib Format: NLM
Interoperability aspects within a telepathology network.

Advances in clinical pathology : the official journal of Adriatic Society of Pathology

Binder B, Schwarzmann P, Schmid J.
PMID: 10358359
Adv Clin Path. 1998 Apr;2(2):170-173.

No abstract available.

Cite
Binder B, Schwarzmann P, Schmid J. Interoperability aspects within a telepathology network. Adv Clin Path. 1998;2(2):170-173
Binder, B., Schwarzmann, P., & Schmid, J. (1998). Interoperability aspects within a telepathology network. Advances in clinical pathology : the official journal of Adriatic Society of Pathology, 2(2), 170-173.
Binder, et al. "Interoperability aspects within a telepathology network." Advances in clinical pathology : the official journal of Adriatic Society of Pathology vol. 2,2 (1998): 170-173.
Binder B, Schwarzmann P, Schmid J. Interoperability aspects within a telepathology network. Adv Clin Path. 1998 Apr;2(2):170-173. PMID: 10358359.
Copy Download .nbib Format: NLM
Is todays telepathology equipment also appropriate for telecytology? A pilot study with pap and blood smears.

Advances in clinical pathology : the official journal of Adriatic Society of Pathology

Schwarzmann P, Schenck U, Binder B, Schmid J.
PMID: 10358361
Adv Clin Path. 1998 Apr;2(2):176-178.

No abstract available.

Cite
Schwarzmann P, Schenck U, Binder B, et al. Is todays telepathology equipment also appropriate for telecytology? A pilot study with pap and blood smears. Adv Clin Path. 1998;2(2):176-178
Schwarzmann, P., Schenck, U., Binder, B., & Schmid, J. (1998). Is todays telepathology equipment also appropriate for telecytology? A pilot study with pap and blood smears. Advances in clinical pathology : the official journal of Adriatic Society of Pathology, 2(2), 176-178.
Schwarzmann, et al. "Is todays telepathology equipment also appropriate for telecytology? A pilot study with pap and blood smears." Advances in clinical pathology : the official journal of Adriatic Society of Pathology vol. 2,2 (1998): 176-178.
Schwarzmann P, Schenck U, Binder B, Schmid J. Is todays telepathology equipment also appropriate for telecytology? A pilot study with pap and blood smears. Adv Clin Path. 1998 Apr;2(2):176-178. PMID: 10358361.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 1041 entries